搜尋結果
Rarebase Is on the Hunt for Therapeutic Opportunities
ACCESSWIRE· 1 年前San Francisco Bay Area residents Jainu and Shruti Jogani had their newborn daughter, Reyna, at ...
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and ...
ACCESSWIRE· 2 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
The Role of Storytelling in Building Inclusion
ACCESSWIRE· 1 年前NORTHAMPTON, MA / ACCESSWIRE / November 9, 2022 / Regions Bank By Candace Higginbotham In his ...
The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of ...
ACCESSWIRE· 2 年前The Bristol Myers Squibb Foundation (BMSF), together with Virginia Commonwealth University ...
Lung Cancer Is Personal: Interview With Lee James
ACCESSWIRE· 1 年前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Bristol Myers Squibb Company non-small cell ...
Why Clinical Trial Diversity Is So Important - and What the Healthcare Sector Can Do
ACCESSWIRE· 1 年前Physicians prescribe medication and design treatment and therapy plans for their patients based ...
Recap: Sustainable Retail Summit 2002 - Day 2
ACCESSWIRE· 2 年前AMSTERDAM / ACCESSWIRE / October 27, 2022 / The Consumer Goods Forum We kicked off an exciting ...
Trees in Screens? How Nanocellulose Is Enhancing Screen Tech Sustainability
ACCESSWIRE· 1 年前NORTHAMPTON, MA / ACCESSWIRE / November 7, 2022 / Love or loathe them: screens have become ...
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 1 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Gilead Sciences: Metastatic Breast Cancer Advocate Urges Black People to Join Clinical Trials
ACCESSWIRE· 2 年前In the spring of 2018, North Carolina native Stephanie Walker went to her first breast cancer ...